The largest database of trusted experimental protocols

111 protocols using mgit 960

1

Automated Mycobacterium Tuberculosis PZA Susceptibility

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Bactec MGIT 960 assay is an automated assay that is used to evaluate M. tuberculosis growth and that also provides information on PZA susceptibility. The assay was performed according to standard guidelines. Briefly, a loopful of M. tuberculosis culture grown on solid 7H10 medium was suspended in a tube containing beads of 1-mm diameter. This was vortexed and incubated for 20 min, and the bacterial suspension was transferred to a separate tube, where its turbidity was adjusted to a 0.5 McFarland standard equivalent. Dilutions (1:5 and 1:50) were then prepared using saline solution, and 500 μl was added to 7H9 medium supplemented with oleic acid-albumin-dextrose-catalase (OADC), with and without 100 μg/ml PZA. The tubes were incubated in the Bactec MGIT 960 instrument. A final readout representing the ratio between the fluorescences of the strain in the presence and absence of PZA was taken to indicate whether the strain was sensitive or resistant to PZA.
+ Open protocol
+ Expand
2

Phenotypic testing for TB drug resistance

Check if the same lab product or an alternative is used in the 5 most similar protocols
Testing for isoniazid and rifampicin in surveys and continuous surveillance uses either molecular or phenotypic methods. For the 7 countries mentioned, culture isolates from enrolled patients were tested using phenotypic methods according to the most recent WHO recommendations at the time [19 ], by either the Löwenstein-Jensen proportion method (Azerbaijan, Bangladesh, Pakistan, the Philippines, and Ukraine) or MGIT 960 (Becton Dickinson, Sparks, MD, US; Belarus and South Africa) at the following concentrations: 0.2 mg/mL isoniazid and 40.0 mg/L rifampicin on Löwenstein-Jensen medium and 0.1 mg/mL isoniazid and 1.0 mg/L rifampicin on MGIT 960.
+ Open protocol
+ Expand
3

Mycobacterium tuberculosis Isolation and Sensitivity

Check if the same lab product or an alternative is used in the 5 most similar protocols
All specimens were stained for acid-fast microscopic examination using Ziehl-Neelsen stain, before sample concentration. MTB isolation was performed as described in detail previously [9 (link)]. Briefly, samples were decontaminated with N-Acetyl-L-Cysteine-Sodium Hydroxide (NALC-NaOH) method and resuspended in 2 ml Phosphate Buffer Saline (PBS): 500 μl were inoculated onto 2 solid slant media (Lowenstein-Jensen; Heipha Diagnostika Biotest, Germany) and 500 μl into liquid culture (MGIT 960; Becton Dickinson, USA). Solid and liquid cultures were considered negative after 42 days of incubation without isolation of any Mycobacteria. Positive cultures were identified as MTB by MGIT TBc Identification Test (Becton Dickinson). Susceptibility of MTB isolates to first-line drugs (Isoniazid, Rifampicin, Ethambutol, Pyrazinamide) was tested by the “gold standard” automatic MGIT 960 system.
“Time to positivity” (TTP) was defined as the number of days from MGIT inoculation to the positive culture result using Epicenter software (Becton Dickinson). An aliquot of 500 μl was tested with Xpert MTB/RIF assay (Xpert, Cepheid, USA) according to manufacturer’s instruction. An aliquot of 500 μl was stored at -20 °C for further use; when culture results were available, only MTB-positive aliquots were archived at -20 °C while the MTB-negative aliquots were discarded.
+ Open protocol
+ Expand
4

Mycobacterium tuberculosis Drug Susceptibility Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drug susceptibility testing (DST) was performed to determine the resistance pattern of isolates to first- and second-line anti-TB drugs. The standard protocol for DST for the first-line drugs streptomycin (STR, 1 μg/mL), isoniazid (INH, 0.1 μg/mL), rifampicin (RIF, 1 μg/mL) and ethambutol (EMB, 5 μg/mL) in MGIT 960 (Becton Dickinson, Oxford Science Park, Oxford, UK) was followed according to the manufacturer’s instructions [6 (link)]. Phenotypic DST for second-line drugs was performed on identified MDR isolates in MGIT 960 (Becton Dickinson, Oxford Science Park, Oxford, UK) using kanamycin (KAN, 2.5 μg/mL) capreomycin (CAP, 2.5 μg/mL), ofloxacin (OFX, 2 μg/mL) and ethionamide (ETH, 5 μg/mL) (Sigma-Aldrich, St. Louis, Mo, USA) [7 ].
+ Open protocol
+ Expand
5

Evaluating GenoType MTBDR plus for Drug Resistance

Check if the same lab product or an alternative is used in the 5 most similar protocols
We included studies that evaluated GenoType MTBDRplus for detection of drug resistance of M. tuberculosis to rifampicin (RIF) and/or isoniazid (INH). Included studies should have compared the GenoType MTBDRplus with one or more reference standard methods that were recommended by the WHO (including L-J PM, Middlebrook 7H10/7H11 agar, BACTEC 460, and BACTEC MGIT 960). The study report must have had extractable data to fill the 4 cells of a 2 × 2 table for diagnostic tests (true resistant-TR, false resistant-FR, false susceptible-FS, and true susceptible-TS).
Relevant publications were excluded if they were duplicated articles, letters without original data, case reports, editorials, and reviews. Studies with fewer than 10 samples were also excluded to reduce selection bias.
+ Open protocol
+ Expand
6

Diagnostic Accuracy of SAT-TB and Acid-Fast Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
All statistical analyses were performed using SPSS 19.0 software. With the BACTEC MGIT 960 culture test as the gold standard, we compared the sensitivity, specificity, positive predictive value, and negative predictive value of SAT-TB, acid-fast staining, and SAT-TB combined with acid-fast staining for the diagnosis of PTB. χ2 examination was adopted, and p < 0.05 was considered statistically significant. The Kappa index was used to assess the consistency of the results. The consistency degree was divided into 3 grades according to the Kappa value which, respectively, are low (<0.4), general (0.4-0.6), and high (>0.6).
+ Open protocol
+ Expand
7

Characterization of M. tuberculosis Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The M. tuberculosis isolates were obtained from clinical specimens collected from patients with TB at the Moscow Research and Clinical Center for Tuberculosis Control, Moscow, Russian Federation. All clinical strains were isolated in 2017–2018 from sputum from newly diagnosed patients prior to starting antituberculosis therapy or no more than one month after the initiation of treatment. The laboratory reference strain M. tuberculosis H37Rv was used as a control strain. For molecular analysis, samples were isolated sequentially, one isolate from one patient, before initiation of treatment. Drug susceptibility tests for rifampicin, isoniazid, streptomycin, ethambutol, pyrazinamide, ofloxacin, moxifloxacin, kanamycin, capreomycin, and amikacin, PAS, and ethionamide were performed using Bactec MGIT 960 as previously described [36 (link),37 ]. The detection of the MIC was performed on MYCOTB microdilution plates as described in [38 (link)]. The MIC of perchlozone was determined using serial dilution method on Middlerook 7H10 agar plates supplemented with the drug at the following concentrations: 0.5, 1, 2, 4, 8, 16, 32, and 64 mg/L.
+ Open protocol
+ Expand
8

Molecular Analysis of Drug-Resistant Tuberculosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The M. tuberculosis strains were obtained from clinical specimens collected from TB patients at the Moscow Research and Clinical Center for Tuberculosis Control. In total, 349 clinical isolates, obtained in 2016–2020 from patients who attended the Moscow Research and Clinical Center for Tuberculosis Control were analyzed: 2016—50 isolates, 2017—87 isolates, 2018—66 isolates, 2019—74 isolates, and 202—72 isolates. For molecular analysis only primary isolates from 2017–2018 were used. They were isolated sequentally, one isolate for one patient, before treatment initiation. Drug susceptibility testing for rifampicin, isoniazid, streptomycin, ethambutol, pyrazinamide, ofloxacin, moxifloxacin, kanamycin, capreomycin, and amikacin, PAS, ethionamide was performed using Bactec MGIT 960 as previously described [45 ,46 ]. Sensititre MYCOTB MIC determination was performed as described in [47 (link)].
The study was approved by the Ethics Committee of the Moscow Government Health Department. The Ethics Committee waived the need for patient consent because the study did not include personal identifiers or clinical data and the samples were analyzed anonymously.
+ Open protocol
+ Expand
9

Linezolid-based Treatment for Drug-resistant Spinal TB

Check if the same lab product or an alternative is used in the 5 most similar protocols
From January 2017 to February 2022, patients with spinal TB were diagnosed through pathological examination or TB culture (BACTEC MGIT 960) in the Orthopedics Department of Beijing Chest Hospital, Capital Medical University. The patients who were treated with linezolid- containing regimens and had their diseased and nondiseased bone collected during surgery were enrolled retrospectively. Exclusion criteria included (1) allergy to linezolid, (2) surgical contraindications such as severe cardiovascular, liver, kidney, or blood system disease or other serious illnesses, and (3) mental illness. All patients orally took linezolid at a dosage of 600 mg per day before undergoing surgery. On the day of the surgery, they orally received 600 mg linezolid before surgery.
The indication for the administration of a linezolid-containing regimen prior to surgery was the suspected drug-resistant TB in the patients. The indication of suspected drug-resistant TB was failure of first-line anti-TB treatment regimen. After the operation, the anti-TB treatment regimen was adjusted based on the results of Xpert MTB/RIF and drug sensitivity testing. If the patient showed no resistance to rifampicin, then linezolid was discontinued.
+ Open protocol
+ Expand
10

Evaluating CF's Impact on M. tuberculosis Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Culture filtrate (CF) prepared either from H37Rv, Beijing or LAM strains was added to Mycobacterial Growth Indicator Tubes (MGIT, Becton-Dickenson) to assess if CF decreased the time to detection of starved M. tuberculosis (H37Rv) cells. Briefly, the media in the MGIT tube was diluted in a 1:1 ratio by removing 3.5 mL of media from the MGIT tubes, except for the control tube, and replacing it with 3.5 mL of either the H37Rv CF or CF produced from the clinical strains. Before inoculating the modified MGIT tubes with 500 µL of the starved H37Rv cells, 800 μL of PANTA reconstituted in OADC was added to the MGIT tubes. The tubes were incubated in the BACTEC MGIT 960 instrument, and the time to positivity was recorded. All experiments were performed in triplicate.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!